Roche Evrysdi gets European Commission nod for babies under two months old with spinal muscular atrophy Ruchika Sharma30 Aug 2023 3:00 PM ISTBasel: Roche has announced that the European Commission has approved the extension of the Evrysdi (risdiplam) European Union (EU) marketing...
ImmunoGen, Takeda ink pact to develop, commercialize Elahere in Japan Ruchika Sharma30 Aug 2023 1:00 PM ISTPer the agreement, ImmunoGen has retained exclusive production rights and will supply product for development and commercial use in Japan.
Europe to face shortage of Eli Lilly diabetes drug Trulicity through September Ruchika Sharma30 Aug 2023 11:30 AM ISTEurope: Europe will continue to face a shortage of Eli Lilly & Co's blockbuster diabetes drug Trulicity through September, the European Medicines...
Pfizer expects to restart production at tornado hit plant by early Q4 Ruchika Sharma30 Aug 2023 10:00 AM ISTNorth Carolina: Pfizer said on Monday it expects to restart production at its North Carolina plant by the beginning of the fourth quarter of...
AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis Ruchika Sharma29 Aug 2023 4:14 PM ISTCambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis...
Venus Remedies gets Saudi marketing approval for Enoxaparin in pre-filled syringes Ruchika Sharma29 Aug 2023 3:00 PM ISTEnoxaparin plays a crucial role in addressing the grave concern of blood clot formation in patients suffering from deep-vein thrombosis, acute...
Sun Pharma aims to spend 7-8 percent of sales in current fiscal on RnD Ruchika Sharma29 Aug 2023 1:00 PM ISTAccording to Shanghvi, the domestic pharmaceutical market size is estimated to reach USD 35-39 billion by 2027, recording 7.5-10.5 per cent compounded...
Janssen seeks expanded USFDA approval for Rybrevant in combination with chemotherapy Ruchika Sharma29 Aug 2023 12:00 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Bristol Myers Squibb gets USFDA nod for Reblozyl as first line treatment of Anemia in lower risk MDS Ruchika Sharma29 Aug 2023 11:09 AM ISTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
Sandoz concludes acquisition of antifungal agent Mycamine from Astellas Ruchika Sharma28 Aug 2023 5:40 PM ISTBasel: Sandoz has successfully completed the acquisition of worldwide brand rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard...
Glenmark recalls 1200 bottles of generic hypertension drug in US over manufacturing issue Ruchika Sharma28 Aug 2023 4:33 PM ISTNew Jersey: Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due...
Indian pharma sector expected to grow at rapid pace: PM Modi Ruchika Sharma28 Aug 2023 3:30 PM ISTCiting the example of the pharmaceutical industry, the prime minister said the sector worth Rs four lakh crore at present is expected to grow to Rs 10...
